Susquehanna International Group, LLP Terns Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$6.49 - $10.8 $580,206 - $965,520	89,400 Added 110.78%	170,100 $1.42 Million
Q2 2024 Aug 15, 2024	BUY	$4.54 - $8.2 $234,264 - $423,119	51,600 Added 177.32%	80,700 $549,000
Q1 2024 May 07, 2024	BUY	$4.86 - $8.19 $31,104 - $52,416	6,400 Added 28.19%	29,100 $190,000
Q4 2023 Feb 14, 2024	BUY	$3.37 - $6.86 $76,499 - $155,722	22,700 New	22,700 $147,000
Q2 2023 Aug 11, 2023	BUY	$7.35 - $13.29 $676,200 - $1.22 Million	92,000 New	92,000 $805,000

167

78.3M

580K

454K

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $220M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.